ARDX250117C3500
- 1.64
- 0.000.00%
Ardelyx Newsroom
Jefferies Maintains Ardelyx(ARDX.US) With Buy Rating, Cuts Target Price to $8
Analysts Offer Insights on Healthcare Companies: Masimo (MASI) and Ardelyx (ARDX)
Why Ardelyx (ARDX) Is One of the Best Biotech Penny Stocks to Invest in Now?
Ardelyx, Inc.'s (NASDAQ:ARDX) Profit Outlook
Ardelyx Insider Bought Shares Worth $996,580, According to a Recent SEC Filing
Ardelyx (ARDX) Sees Its Depressed Stock Turning Around
After a Year of 1.7% Returns, Ardelyx, Inc.'s (NASDAQ:ARDX) Share Price Drop Last Week May Have Less of an Impact on Institutional Investors
Potential Growth for Ardelyx's Ibsrela Amidst Market Volatility
Express News | Ardelyx Inc : Leerink Partners Raises Target Price to $12 From $11
Insider Sale: See Remarks of $ARDX (ARDX) Sells 7,046 Shares
Independent Chairman of the Board of Ardelyx David Mott Buys 18% More Shares
Jefferies Maintains Ardelyx(ARDX.US) With Buy Rating, Announces Target Price $11
Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference
Ardelyx Appoints Joseph Reilly as Principal Accounting Officer
Ardelyx Insider Bought Shares Worth $996,598, According to a Recent SEC Filing
Ardelyx Down as H.C. Wainwright Downgrades Rating on Anticipated Xphozah Sales Drop
Improved Revenues Required Before Ardelyx, Inc. (NASDAQ:ARDX) Shares Find Their Feet
H.C. Wainwright Downgrades Ardelyx(ARDX.US) to Hold Rating, Cuts Target Price to $5.5
Express News | Ardelyx Inc : H.c. Wainwright Cuts to Neutral,
Express News | Ardelyx Responds to District Court Decision Granting Motion to Dismiss